Literature DB >> 2007976

High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection.

C Homann1, K Krogsgaard, C Pedersen, P Andersson, J O Nielsen.   

Abstract

Two hundred eleven HIV-seropositive patients with AIDS, AIDS-related complex, or a CD4+ cell count less than 200 x 10(6) were examined for the presence of hepatitis B virus markers during the course of their HIV infection (median follow-up of 18 months; range of 1 to 107 months). Anti-HBs was detected initially in 138 patients (65%). Sixteen patients (8%) were HBsAg positive at entry. Fourteen had chronic HBV infection of whom 12 initially were positive for HBeAg and HBV DNA; 11 remained positive during follow-up, whereas one seroconverted to anti-HBe and lost HBV DNA. Two patients with chronic HBV infection were initially negative for HBeAg and HBV DNA: one later had reactivated HBV replication and one cleared HBeAg following onset of hepatitis D infection. The last two HBsAg-positive patients had resolving acute HBV infection. Six of the 57 patients who initially were negative for HBV markers acquired HBV infection during follow-up. Four of these six patients developed chronic infection whereas two patients had acute subclinical resolving hepatitis. In addition, four patients became HBsAg positive with their last serum samples, possibly indicating reactivation of HBV infection following progressive immunological and clinical deterioration. None of the patients developed clinical symptoms that could be ascribed to HBV infection, and transaminase elevations were only sporadically recorded. It is concluded that acquisition of HBV infections is not infrequent in HIV-seropositive patients with immune deficiency. Furthermore, the course of both previously established chronic HBV infection and newly acquired HBV infection is modified in such patients, whereas reactivation of past HBV infection seems to be a rare event.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007976

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  11 in total

1.  High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection.

Authors:  Simona Maria Ruta; Rodica Floarea Matusa; Camelia Sultana; Loredana Manolescu; Claudia A Kozinetz; Mark W Kline; Costin Cernescu
Journal:  MedGenMed       Date:  2005-03-28

2.  The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Helen M Chun; Nancy F Crum-Cianflone; Anuradha Ganesan; Amy C Weintrob; R Vincent Barthel; Robert J O'Connell; Brian K Agan
Journal:  Am J Epidemiol       Date:  2010-11-04       Impact factor: 4.897

3.  Correlates of risky injection practices among past-year injection drug users among the US general population.

Authors:  Lauren R Ropelewski; Brent E Mancha; Alicia Hulbert; Abby E Rudolph; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

4.  Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection.

Authors:  Ashwin Balagopal; Hyon S Hwang; Tanner Grudda; Jeffrey Quinn; Richard K Sterling; Mark S Sulkowski; Chloe L Thio
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

5.  HCV, HIV, HBV and HDV infections in intravenous drug addicts.

Authors:  R C Coppola; P E Manconi; R Piro; M L Di Martino; G Masia
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

6.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

7.  Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Anuradha Ganesan; Amy C Weintrob; Nancy F Crum-Cianflone; R Vincent Barthel; Robert J O'Connell; Ann Fieberg; Helen M Chun; Vincent C Marconi; Matthew J Dolan; Brian K Agan
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

8.  GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.

Authors:  Edgar T Overton; Somnuek Sungkanuparph; Michael Klebert; Michael Royal; Debra Demarco-Shaw; William G Powderly; Judith A Aberg
Journal:  Open Virol J       Date:  2011-10-14

9.  High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection.

Authors:  Simona Maria Ruta; Rodica Floarea Matusa; Camelia Sultana; Loredana Manolescu; Claudia A Kozinetz; Mark W Kline; Costin Cernescu
Journal:  J Int AIDS Soc       Date:  2005-03-25       Impact factor: 5.396

10.  Prevalence of hepatitis B surface antigen seropositivity among HIV-infected and non-infected individuals in Nnewi, Nigeria.

Authors:  E C Okocha; O C Oguejiofor; C U Odenigbo; U C Okonkwo; L Asomugha
Journal:  Niger Med J       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.